Planet Briefing

First published · Last updated

Fragment-based drug discovery strategy reveals an unprecedented allosteric binding site in Mycobacterium tuberculosis DNA gyrase

A peer-reviewed journal article reports that a fragment-based drug discovery approach identified a previously unreported allosteric site on Mycobacterium tuberculosis DNA gyrase. Publisher listed as Elsevier BV with publication date 2026-09-01.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
6/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
4/10
Positivity
7/10
Urgency
2/10

Why it matters

The result may be relevant to tuberculosis drug research and design.

Sources

Report an issue